• Concierge Medical Consultants is growing its client base to help provide personalized healthcare to Canadians
  • Concierge provides clients with access to trained physicians in person at their home or place of work
  • ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
  • Concierge Medical is a private medical concierge services provider
  • ScreenPro Security Inc. (SCRN) opened trading at C$0.04 per share

ScreenPro’s (SCRN) wholly-owned operating subsidiary Concierge Medical Consultants is growing its client base to help provide personalized healthcare to Canadians.

Concierge’s Q1 revenue numbers will be reported at the end of this month.

Dr. Jibran Sharif, President of Concierge and Chief Medical Officer at ScreenPro, sat down with Coreena Robertson to discuss the update.

“Our vision is to create a long-lasting longitudinal relationship with one of our highly trained physicians who can see you when you need, can be accessed in real time to deal with your health care needs virtually or in person at your home or place of work. You have the personal contact with your doctor at all times. The concierge medicine space has the potential for explosive growth with US market figures expected to hit 13 billion by 2030.” 

Concierge Medical, acquired by ScreenPro late last year, is an arm’s length private medical concierge services provider incorporated under the laws of British Columbia. It’s comprised of a small group of board-certified practicing emergency physicians.

ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software.

ScreenPro Security Inc. (SCRN) opened trading at C$0.04 per share.

More From The Market Online
stock market down

@ the Bell: Industrials weakness snaps TSX win streak

Industrials led decliners, followed by financials, to snap the TSX’s five-day win streak while energy, utilities and mining provided gains.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.